Table 2

Colour duplex ultrasound (CDU) findings in 9 patients with distal DVT at 3 weeks, and also investigated 6 weeks postoperatively

Patient
3-week CDU
6-week CDU
Prophylaxis
Warfarin
Phlebography

Nr 1
DVT in two soleus veins
Partial regress, only one soleus vein
Placebo
Started at 3 weeks
Negative, no DVT

Nr 2
DVT in one fibular vein
Unchanged from 3 weeks
Dalteparin
No secondary prophylaxis
Initially interpreted as negative, positive at secondary evaluation

Nr 3
DVT in one soleus vein
Progress into gastrocn and fibular veins
Dalteparin
Started at 6 weeks
Positive, performed at 6 weeks

Nr 4
DVT in one soleus vein
Unchanged from 3 weeks
Placebo
No secondary prophylaxis
Initially interpreted as negative, positive at secondary evaluation

Nr 5
DVT in one gastrocn vein
Progress into one more gastrocn vein
Placebo
No secondary prophylaxis
Not performed

Nr 6
DVT in soleus vein
Progress into two fibular veins
Placebo
Started at 6 weeks
Positive, performed at 6 weeks

Nr 7
DVT in two gastrocn veins
Progress into popliteal and calf veins
Placebo
Started at 6 weeks
Not performed

Nr 8
DVT in one soleus vein
Progress into two fibular veins
Dalteparin
Started at 6 weeks
Positive, performed at 6 weeks

Nr 9
DVT in one posterior tibial vein
Progress into two fibular veins
Dalteparin
Started at 6 weeks
Negative at 3 weeks, not performed at 6 weeks

Rosfors et al. Thrombosis Journal 2010 8:4   doi:10.1186/1477-9560-8-4

Open Data